Resumen de Change in the air.
This article discusses the transition away from the use of chlorofluorocarbons (CFCs) in albuterol inhalers used to treat asthma. The increased cost of using hydroflouroalkane (HFA) propellants is noted. Research by the pharmacist Leslie Hendeles indicating that the motivation behind the switch from CFCs to HFAs benefits pharmaceutical companies rather than the environment is noted.
